Literature DB >> 26825173

Breast Tumor Kinase (Brk/PTK6) Is Induced by HIF, Glucocorticoid Receptor, and PELP1-Mediated Stress Signaling in Triple-Negative Breast Cancer.

Tarah M Regan Anderson1, Shi Hong Ma2, Ganesh V Raj2, John A Cidlowski3, Taylor M Helle1, Todd P Knutson1, Raisa I Krutilina4, Tiffany N Seagroves4, Carol A Lange5.   

Abstract

Cancer cells use stress response pathways to sustain their pathogenic behavior. In breast cancer, stress response-associated phenotypes are mediated by the breast tumor kinase, Brk (PTK6), via the hypoxia-inducible factors HIF-1α and HIF-2α. Given that glucocorticoid receptor (GR) is highly expressed in triple-negative breast cancer (TNBC), we investigated cross-talk between stress hormone-driven GR signaling and HIF-regulated physiologic stress. Primary TNBC tumor explants or cell lines treated with the GR ligand dexamethasone exhibited robust induction of Brk mRNA and protein that was HIF1/2-dependent. HIF and GR coassembled on the BRK promoter in response to either hypoxia or dexamethasone, indicating that Brk is a direct GR/HIF target. Notably, HIF-2α, not HIF-1α, expression was induced by GR signaling, and the important steroid receptor coactivator PELP1 was also found to be induced in a HIF-dependent manner. Mechanistic investigations showed how PELP1 interacted with GR to activate Brk expression and demonstrated that physiologic cell stress, including hypoxia, promoted phosphorylation of GR serine 134, initiating a feed-forward signaling loop that contributed significantly to Brk upregulation. Collectively, our findings linked cellular stress (HIF) and stress hormone (cortisol) signaling in TNBC, identifying the phospho-GR/HIF/PELP1 complex as a potential therapeutic target to limit Brk-driven progression and metastasis in TNBC patients. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26825173      PMCID: PMC4794366          DOI: 10.1158/0008-5472.CAN-15-2510

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Dexamethasone decreases xenograft response to Paclitaxel through inhibition of tumor cell apoptosis.

Authors:  Diana Pang; Masha Kocherginsky; Thomas Krausz; So-Young Kim; Suzanne D Conzen
Journal:  Cancer Biol Ther       Date:  2006-08-02       Impact factor: 4.742

2.  Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells.

Authors:  Emily J Faivre; Carol A Lange
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

3.  Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells.

Authors:  Julie Hanson Ostrander; Andrea R Daniel; Kristopher Lofgren; Celina G Kleer; Carol A Lange
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

4.  Hypoxia-inducible factor 1alpha is closely linked to an aggressive phenotype in breast cancer.

Authors:  Yutaka Yamamoto; Mutsuko Ibusuki; Yasuhiro Okumura; Teru Kawasoe; Kazuharu Kai; Kenichi Iyama; Hirotaka Iwase
Journal:  Breast Cancer Res Treat       Date:  2007-09-06       Impact factor: 4.872

Review 5.  VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacy.

Authors:  C Lance Cowey; W Kimryn Rathmell
Journal:  Curr Oncol Rep       Date:  2009-03       Impact factor: 5.075

6.  Extranuclear coactivator signaling confers insensitivity to tamoxifen.

Authors:  Rakesh Kumar; Hao Zhang; Caroline Holm; Ratna K Vadlamudi; Goran Landberg; Suresh K Rayala
Journal:  Clin Cancer Res       Date:  2009-05-26       Impact factor: 12.531

7.  Brk is coamplified with ErbB2 to promote proliferation in breast cancer.

Authors:  Bin Xiang; Kiranam Chatti; Haoqun Qiu; B Lakshmi; Alexander Krasnitz; Jim Hicks; Min Yu; W Todd Miller; Senthil K Muthuswamy
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

8.  Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.

Authors:  Rajib Rajhans; Sujit Nair; Alan H Holden; Rakesh Kumar; Rajeshwar Rao Tekmal; Ratna K Vadlamudi
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

9.  MNAR functionally interacts with both NH2- and COOH-terminal GR domains to modulate transactivation.

Authors:  Midori Kayahara; Jacqueline Ohanian; Vasken Ohanian; Andrew Berry; Ratna Vadlamudi; David W Ray
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-08-05       Impact factor: 4.310

10.  Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients.

Authors:  M Aubele; A K Walch; N Ludyga; H Braselmann; M J Atkinson; B Luber; G Auer; S Tapio; T Cooke; J M S Bartlett
Journal:  Br J Cancer       Date:  2008-09-09       Impact factor: 7.640

View more
  23 in total

Review 1.  Steroid Hormone Receptor Positive Breast Cancer Patient-Derived Xenografts.

Authors:  Shawna B Matthews; Carol A Sartorius
Journal:  Horm Cancer       Date:  2016-10-28       Impact factor: 3.869

2.  Using Radiolabeled 3'-Deoxy-3'-18F-Fluorothymidine with PET to Monitor the Effect of Dexamethasone on Non-Small Cell Lung Cancer.

Authors:  Christopher I McHugh; Monica R Thipparthi; Jawana M Lawhorn-Crews; Lisa Polin; Shirish Gadgeel; Janice Akoury; Thomas J Mangner; Kirk A Douglas; Jing Li; Manohar Ratnam; Anthony F Shields
Journal:  J Nucl Med       Date:  2018-04-19       Impact factor: 10.057

Review 3.  Targeting protein tyrosine kinase 6 in cancer.

Authors:  Milica B Gilic; Angela L Tyner
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-09-18       Impact factor: 10.680

4.  Splice variants of cytosolic polyadenylation element-binding protein 2 (CPEB2) differentially regulate pathways linked to cancer metastasis.

Authors:  James T DeLigio; Grace Lin; Charles E Chalfant; Margaret A Park
Journal:  J Biol Chem       Date:  2017-09-13       Impact factor: 5.157

5.  HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer via PI3K/AKT/mTOR signaling.

Authors:  Jie Bai; Wei-Bin Chen; Xiao-Yu Zhang; Xiao-Ning Kang; Li-Jun Jin; Hui Zhang; Zun-Yi Wang
Journal:  World J Stem Cells       Date:  2020-01-26       Impact factor: 5.326

Review 6.  90 YEARS OF PROGESTERONE: Steroid receptors as MAPK signaling sensors in breast cancer: let the fates decide.

Authors:  Amy R Dwyer; Thu H Truong; Julie H Ostrander; Carol A Lange
Journal:  J Mol Endocrinol       Date:  2020-07       Impact factor: 5.098

7.  Discovery of a Glucocorticoid Receptor (GR) Activity Signature Using Selective GR Antagonism in ER-Negative Breast Cancer.

Authors:  Diana C West; Masha Kocherginsky; Eva Y Tonsing-Carter; D Nesli Dolcen; David J Hosfield; Ricardo R Lastra; Jason P Sinnwell; Kevin J Thompson; Kathleen R Bowie; Ryan V Harkless; Maxwell N Skor; Charles F Pierce; Sarah C Styke; Caroline R Kim; Larischa de Wet; Geoffrey L Greene; Judy C Boughey; Matthew P Goetz; Krishna R Kalari; Liewei Wang; Gini F Fleming; Balázs Györffy; Suzanne D Conzen
Journal:  Clin Cancer Res       Date:  2018-04-10       Impact factor: 12.531

Review 8.  Modifications to glucocorticoid and progesterone receptors alter cell fate in breast cancer.

Authors:  Katherine A Leehy; Tarah M Regan Anderson; Andrea R Daniel; Carol A Lange; Julie H Ostrander
Journal:  J Mol Endocrinol       Date:  2016-02-01       Impact factor: 5.098

9.  Taxol Induces Brk-dependent Prosurvival Phenotypes in TNBC Cells through an AhR/GR/HIF-driven Signaling Axis.

Authors:  Tarah M Regan Anderson; Shihong Ma; Carlos Perez Kerkvliet; Yan Peng; Taylor M Helle; Raisa I Krutilina; Ganesh V Raj; John A Cidlowski; Julie H Ostrander; Kathryn L Schwertfeger; Tiffany N Seagroves; Carol A Lange
Journal:  Mol Cancer Res       Date:  2018-07-10       Impact factor: 5.852

Review 10.  Stress sensing within the breast tumor microenvironment: how glucocorticoid receptors live in the moment.

Authors:  Carlos Perez Kerkvliet; Thu H Truong; Julie Hanson Ostrander; Carol A Lange
Journal:  Essays Biochem       Date:  2021-12-17       Impact factor: 8.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.